Total Management of Risk Factors in Rheumatoid Arthritis Patients to Lower Morbidity and Mortality (TOMORROW study)

Conditions

Rheumatoid Arthritis

Matsumoto Y, Shivappa N, Sugioka Y, Tada M, Okano T, Mamoto K, Inui K, Habu D, Hebert JR, Koike T.

2021-04-0822 citations

10.1186/s13075-021-02478-y

Evaluation of work disability in Japanese patients with rheumatoid arthritis: from the TOMORROW study.

Anno S, Sugioka Y, Inui K, Tada M, Okano T, Mamoto K, Koike T.

2018-03-106 citations

10.1007/s10067-018-4060-z

Loss of lean body mass affects low bone mineral density in patients with rheumatoid arthritis – results from the TOMORROW study

Tadashi Okano, Kentaro Inui, Masahiro Tada, Y. Sugioka, K. Mamoto et al. (8 authors)

Modern Rheumatology2017-02-0222 citations

10.1080/14397595.2017.1289645

Relationships between serum 25-hydroxycalciferol, vitamin D intake and disease activity in patients with rheumatoid arthritis--TOMORROW study.

Matsumoto Y, Sugioka Y, Tada M, Okano T, Mamoto K, Inui K, Habu D, Koike T.

2014-09-1118 citations

10.3109/14397595.2014.952487

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with rheumatoid arthritis who are treated with or without biologics and healthy subjects

Exclusion criteria

Exclusion criteria: The person who cannot come for testing regularly, patients with undifferentiated arthritis

Design outcomes

Primary

Measure	Time frame
Osteoporotic fracture, fall, cardiovascular event, DAS28	—

Secondary

Measure	Time frame
Bone mineral density	—

Countries

Japan

Contacts

Public ContactTatsuya Koike

Osaka City University Medical School Center for Senile Degenerative Disorders (CSDD)

tatsuya@med.osaka-cu.ac.jp06-6645-3984

Outcome results